Yuqi Hu

43 posts

Yuqi Hu

Yuqi Hu

@YuqiHu_

student at HKU

Katılım Ağustos 2023
59 Takip Edilen36 Takipçiler
Yuqi Hu retweetledi
Yin Zhang
Yin Zhang@zhangyin0904·
Happy to share our study on global Clostridioides difficile infection treatment trends in International Journal of Antimicrobial Agents. Use of fidaxomicin and oral vancomycin is rising globally, but access remains unequal across regions and incomes. 🔗 sciencedirect.com/science/articl…
English
0
31
16
677
Yuqi Hu retweetledi
Prof Ian Wong
Prof Ian Wong@Prof_IanWong·
Major milestone of HK Pharmacy Profession Primary Healthcare Commission announces Community Drug Formulary mechanism and Guidelines of Practice for Community Pharmacy to pave way for launch of Community Pharmacy Programme next year (with photo) info.gov.hk/gia/general/20…
English
0
11
10
539
Yuqi Hu retweetledi
Edmund Cheung
Edmund Cheung@edmundccheung·
Our multinational database study in @eClinicalMed compared antihypertensive prescribing trends in Hong Kong, United Kingdom, Sweden, and Australia, providing evidence on the use of blood pressure-lowering drugs before and after a diagnosis of dementia. sciencedirect.com/science/articl…
English
0
43
22
1.3K
Yuqi Hu retweetledi
Franco WT Cheng
Franco WT Cheng@kfranco_c·
Our new meta-analysis in Hypertension Research confirms Sacubitril/Valsartan effectively reduces both office and out-of-office blood pressure. This was a fantastic international collaboration with our colleagues at Chulalongkorn University. nature.com/articles/s4144…
English
0
36
16
571
Yuqi Hu retweetledi
Prof Ian Wong
Prof Ian Wong@Prof_IanWong·
Antiseizure medications consumption in 73 countries and regions from 2... sciencedirect.com/science/articl… Our Aston U, HKU, UCL, WHO study shows that inequities in access to newer antiseizure drugs in developing countries where valproate used a lot. Good risk management is needed
English
0
36
18
1.1K
Yuqi Hu retweetledi
Luna Wei Yue
Luna Wei Yue@WeiYLuna·
Excited to share our latest study in @TheLancet: long-acting injectable antipsychotics (LAIAs) are more effective than oral and equally safe for older people, except for higher risk of EPS with typical LAIAs, but not with atypical LAIAs. @Esther_CSMPRHKU thelancet.com/journals/lanps…
English
0
40
22
1K
Yuqi Hu retweetledi
Shirley Xue Li
Shirley Xue Li@snowly12191·
Our simulation model supports the cost-effectiveness of PSA screening in China. Personalised screening based on genetic risk may provide an efficient alternative to uniform strategies by reducing unnecessary interventions for lower risk individual.sciencedirect.com/science/articl…
English
0
33
14
747
Yuqi Hu retweetledi
Prof Ian Wong
Prof Ian Wong@Prof_IanWong·
"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read ascpt.onlinelibrary.wiley.com/doi/10.1002/cp…
English
0
47
29
1.1K
Yuqi Hu retweetledi
Celine Chui HKU
Celine Chui HKU@ChuiCeline·
Duramax, a reinforcement learning framework designed to optimize long-term lipid-modifying therapy for CVD prevention. It helps bridge the gap between AI-driven precision and real-world clinical utility. nature.com/articles/s4174…
English
1
40
22
834
Yuqi Hu
Yuqi Hu@YuqiHu_·
Thrilled to share our study in The Lancet Psychiatry @TheLancet ! Deep gratitude to Dr. Lai @FranciscoTTLai1 for his guidance in this research and my PhD process. Using Hong Kong data, we reveal new evidence on clozapine use and infections. 💊
Francisco TT Lai@FranciscoTTLai1

My lab’s latest @TheLancet Psychiatry study showing increased infections following clozapine use; excellent work by my student @YuqiHu_ and the rest of my team, with special thanks to psychiatry, family medicine, & pharmacy colleagues & collaborators 🥂 thelancet.com/journals/lanps…

English
0
1
3
148